Drugs / Peppermint oil
Peppermint oil
Trials 15
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT05282706 | May 2022 → Sep 2025 | — | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
| Phase 1 | NCT04497870 | Jul 2020 → Sep 2023 | — | Baylor College of Medicine | Withdrawn | No outcome recorded |
| Phase 1 | NCT03295747 | Oct 2017 → Mar 2019 | — | Robert Shulman, M.D. | Completed | No outcome recorded |
| Phase 1 | NCT01269671 | Jan 2011 → Jan 2012 | dyspepsia, irritable bowel syndrome | Medical College of Wisconsin | Withdrawn | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04845217 | Sep 2021 → Jun 2023 overdue | interstitial cystitis | University of Louisville | Recruiting | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT05398965 | Nov 2020 → Jan 2021 | COVID-19 | Hasanuddin University | Completed | No outcome recorded |
| Phase 2 | NCT04091789 | Sep 2019 → Mar 2020 | dysmenorrhea, migraine disorder, mood disorder | Pure Green | Unknown | No outcome recorded |
| Phase 2 | NCT02291445 | Mar → Jul 2015 | colonic disorder, irritable bowel syndrome | Maastricht University Medical Center | Completed | No outcome recorded |
| Phase 33 trials · 1 missed | ||||||
| Phase 3 | NCT05799053 | May 2022 → Nov 2024 | irritable bowel syndrome | St. Antonius Hospital | Completed | Missed primary |
| Phase 3 | NCT02588248 | Apr → May 2017 | colon carcinoma, polyp of colon | University Hospitals Cleveland Medical Center | Terminated | No outcome recorded |
| Phase 3 | NCT02716285 | Aug 2016 → May 2018 | functional colonic disease, irritable bowel syndrome | Maastricht University Medical Center | Completed | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT07537101 | Jun → Dec 2026 expected | decubitus ulcer | Ali Abd-Alredha Hussein | Not yet recruiting | No outcome recorded |
| — | NCT05559814 | Mar 2021 → May 2022 | polyp of colon | Mahidol University | Completed | No outcome recorded |
| — | NCT02163369 | Jul 2014 → Jun 2015 | — | Central DuPage Hospital | Unknown | No outcome recorded |
| — | NCT00456404 | Feb → Jun 2005 | breast disorder | Tabriz University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | peppermint oil | “A sublingual tablet containing 30 mg of cannabidiol (CBD), 1 mg tetrahydrocannabinol (THC), 97 mg palmitoylethanolamide (PEA), and a 0.2 mg combination of myrcene,...” NCT04091789 ↗13“The Eucalyptus Oil pack contains Oleum Eucalyptus citriodora, Oleum Eucalyptus globulus, and Peppermint oil, given 4 times daily for 45 minutes each frequency, applied to the mask.” NCT05398965 ↗ “Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety.” NCT02163369 ↗ “Topical gel containing a combination of natural Aloe vera extract and peppermint oil.” NCT07537101 ↗ “Menthae piperitae aetheroleum/peppermint oil (enteric coated capsule)” NCT02291445 ↗ |
| Known as | menthae piperitae aetheroleum | “Peppermint oil, menthae piperitae aetheroleum” NCT02716285 ↗ |
| Known as | mentharil | “Melatonin, Peppermint Oil (mentharil), and Simethicone” NCT01269671 ↗ |
| Known as | peppermint water | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00456404 ↗ |
| Known as | PMO | “Peppermint oil (PMO) is effective in the treatment of functional abdominal pain disorders, but its mechanism of action is unclear.” PMID 35048535 ↗ Jan 2022 |
| Modality | Traditional medicine (herbal / TCM) | “peppermint water, an old household remedy” NCT00456404 ↗ |
| Route | Topical | “a topical preparation of peppermint water” NCT00456404 ↗ |